.

0 (hodnocen0 x )

EB

ONLINE

Havertown : International Atomic Energy Agency, 2021

1 online resource (268 pages)

ISBN 9789201016218 (electronic bk.)

Non-Serial Publications

Print version: IAEA Integrated Non-Invasive Cardiovascular Imaging: a Guide for the Practitioner Havertown : International Atomic Energy Agency,c2021

Intro -- Chapter 1INTRODUCTION -- 1.1. Background -- 1.2. Objective -- 1.3. Scope -- 1.4. Structure -- Part IFUNDAMENTALS OF NON-INVASIVE CARDIAC IMAGING -- Chapter 2NUCLEAR CARDIOLOGY:SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY -- 2.1. Hardware -- 2.2 Software -- 2.3. Hybrid SPECT-CT imaging systems -- 2.3.1. Techniques -- 2.3.2. Types of stress used in GSPECT procedures -- 2.3.3. Acquisition and interpretation of images -- 2.3.4. Reporting -- 2.4. Safety -- 2.5. Key messages -- References to Chapter 2 -- Chapter 3NUCLEAR CARDIOLOGY:POSITRON EMISSION TOMOGRAPHY -- 3.1. Basic principles -- 3.1.1. Hardware -- 3.1.2. Software -- 3.2. Cardiac PET radiotracers -- 3.2.1. 82Ru -- 3.2.2. 13N ammonia -- 3.2.3. 15O water -- 3.2.4. Flurpiridaz -- 3.2.5. 18F-FDG -- 3.3. Imaging protocols -- 3.3.1. MPI and MBF quantification -- 3.3.2. Myocardial viability and sarcoid imaging -- 3.3.3. Coronary artery calcium scoring with PET-CT -- 3.3.4. Display of PET perfusion rest-stress and perfusion-metabolism images -- 3.3.5. Elements of a comprehensive cardiac PET report -- 3.4. Key messages -- References to Chapter 3 -- Chapter 4ECHOCARDIOGRAPHY -- 4.1. Physics of echocardiography -- 4.2. 2-D and 3-D echocardiography -- 4.3. Doppler echocardiography -- 4.3.1. Spectral Doppler imaging -- 4.3.2. Tissue Doppler imaging -- 4.4. Speckle tracking echocardiography -- 4.5. Transthoracic and transoesophageal echocardiography -- 4.6. 3-D echocardiography -- 4.7. Contrast echocardiography -- 4.8. Key messages -- References to Chapter 4 -- Chapter 5CARDIAC MAGNETIC RESONANCE IMAGING -- 5.1. Basics of magnetic resonance imaging -- 5.2. Cardiac magnetic resonance -- 5.3. Blood flow evaluation using CMR -- 5.4. 4-D flow cardiac magnetic resonance -- 5.5. Safety considerations -- 5.6. Key messages -- References to Chapter 5 -- Chapter 6CARDIAC COMPUTED TOMOGRAPHY.

11.7. Key messages -- References to Chapter 11 -- Chapter 12HEART FAILURE -- 12.1. Global and regional left ventricular function -- 12.2. Left ventricular size and shape -- 12.3. Myocardial morphology and function -- 12.4. Myocardial ischaemia or viability -- 12.5. Left atrium and right ventricle -- 12.6. Valve disease -- 12.7. Key messages -- References to Chapter 12 -- Chapter 13CARDIOMYOPATHIES -- 13.1. Hypertrophic cardiomyopathy -- 13.2. Dilated cardiomyopathy -- 13.3. Restrictive cardiomyopathy -- 13.4. Specific cardiomyopathies -- 13.4.1. Cardiac amyloidosis -- 13.4.2. Cardiac sarcoidosis -- 13.4.3. Anderson-Fabry disease -- 13.5. Classification of cardiomyopathies according to left ventricular systolic or diastolic dysfunction -- 13.6. Key messages -- References to Chapter 13 -- Chapter 14PERICARDIAL DISEASES -- 14.1. Acute pericarditis -- 14.1.1. Definition and clinical presentation -- 14.1.2. Imaging algorithms and modalities for acute pericarditis based on clinical presentation -- 14.2. Cardiac tamponade -- 14.2.1. Cardiac computed tomography -- 14.2.2. Cardiac magnetic resonance -- 14.3. Constrictive pericarditis -- 14.3.1. Definition and clinical presentation -- 14.3.2. Imaging modalities for constrictive pericarditis -- 14.4. Key messages -- References to Chapter 14 -- Chapter 15PRIMARY VALVE DISEASES -- 15.1. Causes of valve disease -- 15.2. Signs, symptoms and diagnosis of valvular heart disease -- 15.3. Classification of the severity of primary valvular pathologies -- 15.4. Pre-operative imaging evaluations in patients with rheumatic mitral stenosis -- 15.5. Role of CMR imaging in patients with primary valve disease -- 15.6. Assessment of coronary anatomy in patients with primary valvular heart disease prior to surgical interventions -- 15.7. Follow-up of patients with prosthetic valves.

18.5. Cardiac magnetic resonance.

9.3. Lessons learned from observational data: Examples in nuclear cardiology -- 9.4. Defining comparative effectiveness -- 9.5. Examples of controlled clinical trials -- 9.6. Examples of comparative effectiveness trials -- 9.7. Therapeutic risk reduction: Guiding therapeutic decision making -- 9.8. Assimilating evidence into evaluation algorithms -- 9.9. Key messages -- References to Chapter 9 -- Chapter 10STABLE CORONARY ARTERY DISEASE -- 10.1. Clinical presentation -- 10.2. Risk prediction models and pre-test probability -- 10.2.1. Advantages of prediction models -- 10.2.2. Disadvantages of prediction models -- 10.3. Role of basic investigations -- 10.4. Role of non-invasive imaging in clinical decision making -- 10.5. Imaging algorithms based on clinical presentation -- 10.5.1. Investigation of suspected stable coronary artery disease -- 10.5.2. Important considerations when choosing a diagnostic test -- 10.5.3. Pre-operative risk assessment prior to non-cardiac surgery -- 10.5.4. Incidental identification of CAD on imaging performed for other reasons -- 10.6. Conclusion -- 10.7. Key messages -- References to Chapter 10 -- Chapter 11ACUTE CORONARY SYNDROMES -- 11.1. Definition of acute coronary syndrome -- 11.2. Pathophysiology of acute coronary syndrome -- 11.3. Role of non-invasive imaging in acute coronary syndrome -- 11.4. Clinical utility of non-invasive imaging in acute coronary syndrome -- 11.4.1. Echocardiography -- 11.4.2. Coronary computed tomography angiography -- 11.4.3. Cardiac magnetic resonance imaging -- 11.4.4. Radionuclide imaging: SPECT and PET -- 11.5. Case based approach to imaging in acute coronary syndromes -- 11.5.1. Suspected ACS: Case 1 -- 11.5.2. Suspected ACS: Case 2 -- 11.5.3. NSTE-ACS: Case 3 -- 11.5.4. STE-ACS: Case 4 -- 11.5.5. STE-ACS: Case 5 -- 11.6. Myocardial infarction with non-obstructive coronary arteries.

15.8. Role of imaging in planning percutaneous interventions for aortic stenosis -- 15.9. Role of nuclear cardiology in patients with primary valve disease -- 15.10. Follow-up and treatment of patients with advanced valvular heart disease -- 15.11. Case presentation -- 15.12. Key messages -- References to Chapter 15 -- Chapter 16CARDIO-ONCOLOGY -- 16.1. Definition -- 16.2. Clinical presentations -- 16.2.1. Asymptomatic left ventricular dysfunction -- 16.2.2. Heart failure -- 16.2.3. Vascular disease -- 16.2.4. Pericardial disease -- 16.2.5. Valvular complications -- 16.3. Imaging algorithms based on clinical presentation -- 16.4. Selection of an imaging modality -- 16.5. Echocardiography -- 16.6. Nuclear imaging -- 16.7. Cardiac magnetic resonance imaging -- 16.8. Key messages -- References to Chapter 16 -- Chapter 17ADULT CONGENITAL HEART DISEASE -- 17.1. Guidelines -- 17.2. Clinical presentation -- 17.3. Imaging modalities -- 17.4. Specific disease entities -- 17.4.1. Atrial septal defect -- 17.4.2. Ventricular septal defect -- 17.4.3. Atrioventricular septal defect -- 17.4.4. Patent ductus arteriosus -- 17.4.5. Left sided heart obstructive lesions (aortic valve disease, coarctation of aorta) -- 17.4.6. Right ventricular outflow tract obstruction (pulmonary stenosis) -- 17.4.7. Coronary artery abnormalities -- 17.4.8. Pulmonary hypertension and Eisenmenger’s syndrome -- 17.4.9. Tetralogy of Fallot -- 17.4.10. Dextrotransposition of the great arteries -- 17.4.11. Congenitally corrected transposition of the great arteries -- 17.4.12. Ebstein’s anomaly -- 17.4.13. Single ventricle diseases -- 17.5. Key messages -- References to Chapter 17 -- Chapter 18ENDOCARDITIS -- 18.1. Epidemiology and clinical presentation -- 18.2. Diagnostic imaging -- 18.3. Echocardiography -- 18.4. Multislice gated cardiac computed tomography.

6.1. Basic principles -- 6.2. Computed tomography hardware and software -- 6.2.1. Minimum standards -- 6.2.2. Recent developments -- 6.2.3. Software for coronary computed tomography angiography -- 6.2.4. Software for determining the coronary artery calcium score -- 6.3. Techniques -- 6.3.1. Patient preparation -- 6.3.2. CCTA image acquisition -- 6.3.3. CCTA image analysis -- 6.4. Advanced CCT techniques -- 6.4.1. CACS image acquisition and reconstruction -- 6.4.2. CACS image analysis -- 6.4.3. Coronary artery calcification on non-dedicated imaging -- 6.4.4. Non-coronary cardiac imaging -- 6.5. Safety -- 6.5.1. Radiation dose parameters -- 6.5.2. Radiation dose of CCTA -- 6.5.3. Radiation dose risks -- 6.5.4. Iodinated contrast -- 6.5.5. Other medication -- 6.6. Key messages -- References to Chapter 6 -- Part IICLINICAL APPLICATIONS -- Chapter 7INTEGRATED NON-INVASIVE CARDIOVASCULAR IMAGING IN ROUTINE CLINICAL PRACTICE -- 7.1. Concept -- 7.2. Integrating the basics: ETT and echocardiography -- 7.2.1. Integrating with more advanced imaging using nuclear cardiology and computed tomography -- 7.2.2. Integrating basic modalities with other modalities -- 7.2.3. Key aspects for successful integration between modalities -- 7.3. Future of integrated cardiovascular imaging -- 7.4. Key messages -- References to Chapter 7 -- Chapter 8APPROPRIATE USE OF NON-INVASIVE CARDIAC IMAGING TECHNIQUES -- 8.1. Framework of appropriate imaging guidelines -- 8.2. Definition of appropriateness and application of guidelines -- 8.3. Future directions -- 8.4. Key messages -- References to Chapter 8 -- Chapter 9CURRENT EVIDENCE AND LESSONS LEARNED FROM RANDOMIZED TRIALS IN CARDIOVASCULAR IMAGING -- 9.1. Hierarchy of clinical research evidence in cardiovascular imaging -- 9.2. Evidentiary standards for quality cardiovascular imaging.

001905541

express

(Au-PeEL)EBL6985999

(MiAaPQ)EBC6985999

(OCoLC)1319214149